| Duetact Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Duetact 4 mg-30 mg | tablet | oral | 1.0 each | OTC |
| Duetact 2 mg-30 mg | tablet | oral | 1.0 each | OTC |
US OKs new heart failure warning on diabetes drugs - Reuters
The warnings will appear in a "black box" on Glaxo's Avandia, Avandaryl and Avandamet, as well as on Takeda's Actos and Duetact, the Food and Drug ...
Wed Aug 15 03:02:20 -0400 2007
FDA advises stronger diabetes drug warning - Science Daily (press release)
The products include the brands Avandia, Actos, Avandaryl, Avandamet and Duetact -- all manufactured by GlaxoSmithKline and Takeda. ...
Wed Aug 15 06:13:08 -0400 2007
Manufacturers of Some Diabetes Drugs to Strengthen Warning on ... - Pharmaceutical Processing
... Actos (pioglitazone) Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepride). ...
Tue Aug 21 12:08:09 -0400 2007
glimepiride - A sulfonylurea with antihyperglycemic activity. Glimepiride binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, thereby reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-gated calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin, and thereby results in a reduction of the blood glucose level. In addition, this agent increases the sensitivity of peripheral tissues to insulin.
pioglitazone hydrochloride